In contrast to FOS, while 2′-FL and 3′-FL effectively mitigated barrier dysfunction caused by IL-6 and symptoms of DSS-induced colitis, they bolstered the expression of tight junction proteins (ZO-1 and Claudin-1) to enhance intestinal barrier function. The gene discussed is TJP1; the disease is colitis.